Results 141 to 150 of about 13,667 (153)
ABSTRACTAntimicrobial resistance (AMR) poses a global threat to public health, with projections estimating 10 million deaths annually by 2050 if current trends persist. Actinobacteria, renowned for their biosynthetic capacity, are a key source of bioactive compounds, producing over 75% of known antibiotics.
Ariel de Figueiredo Nogueira Mesquita +5 more
openalex +3 more sources
The aim of the study was to isolate, identify, and analyze the phylogenetic relationship of the secondary metabolite-producing actinobacterial strains isolated from the mangrove ecosystem of Krishna district, Andhra Pradesh. The potent bioactive metabolite-producing strain was isolated and designated as VLK-104.
Krishna Naragani
openalex +2 more sources
Introduction: There is an urgent requirement to develop novel antimicrobial agents that can counter the rising problem of antibiotic-resistant disease-causing microorganisms. The actinobacteria are a prolific source of natural products, and most of the known antibiotics are produced by these mycelial bacteria. Studies of rare actinobacteria can enhance
Ali Arkan Majhool +2 more
openalex +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Screening rare filamentous actinobacteria for novel antimycobacterial compounds
2022Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (M.tb). According to the World Health Organization (WHO), TB is one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent. There were an estimated 1.2 million TB deaths among HIV negative people in 2019 and an additional 208 ...
openaire +1 more source
The burden of rare cancers in the United States
Ca-A Cancer Journal for Clinicians, 2017Carol Desantis, Ahmedin Jemal
exaly
Actinobacteria: Current research and perspectives for bioremediation of pesticides and heavy metals
Chemosphere, 2017Analía Alvarez +2 more
exaly

